Structural analysis identifies an orally active PCNA inhibitor that inhibits the growth of small cell lung cancer cells without causing significant toxicity to nonmalignant cells
- Resource Type
- Abstract
- Source
- In
Journal of Thoracic Oncology February 2016 11(2) Supplement:S22-S23 - Subject
- Language
- ISSN
- 1556-0864